Literature DB >> 29196972

Proximal total splenic artery embolization for refractory hepatic encephalopathy.

Harufumi Maki1, Junichi Kaneko2, Junichi Arita1, Nobuhisa Akamatsu1, Yoshihiro Sakamoto1, Kiyoshi Hasegawa1, Sumihito Tamura1, Hidemasa Takao1,3, Eisuke Shibata1,3, Norihiro Kokudo1.   

Abstract

A Japanese woman with a history of Kasai operation for biliary atresia had living-donor liver transplantation at the age of 22. The first episode of refractory HE and late cellular rejection was treated by a high dose of methylprednisolone. The second episode of refractory HE was treated by balloon-occluded retrograde transvenous obliteration for a spleno-renal shunt. However, the third episode of refractory HE occurred 11 years after liver transplantation. The liver cirrhosis and hypersplenism were present with a Child-Pugh score of C-10. Although portal vein flow was hepatopetal, superior mesenteric vein flow regurgitated. We performed proximal total splenic artery embolization (TSAE). Superior mesenteric vein flow changed to a hepatopetal direction and she became clear. At a year after proximal TSAE, her spleen volume had decreased to 589 mL (20% decrease) on computed tomography. She is well and has a Child-Pugh score of 8 without overt HE. We report the first case of refractory HE treated by proximal TSAE that is a possible less invasive treatment option for a selected patient.

Entities:  

Keywords:  Hepatofugal; Living-donor liver transplantation; Proximal total splenic artery embolization; Refractory hepatic encephalopathy; Superior mesenteric vein

Mesh:

Year:  2017        PMID: 29196972     DOI: 10.1007/s12328-017-0805-5

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  17 in total

1.  Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.

Authors:  A Demetris; D Adams; C Bellamy; K Blakolmer; A Clouston; A P Dhillon; J Fung; A Gouw; B Gustafsson; H Haga; D Harrison; J Hart; S Hubscher; R Jaffe; U Khettry; C Lassman; K Lewin; O Martinez; Y Nakazawa; D Neil; O Pappo; M Parizhskaya; P Randhawa; S Rasoul-Rockenschaub; F Reinholt; M Reynes; M Robert; A Tsamandas; I Wanless; R Wiesner; A Wernerson; F Wrba; J Wyatt; H Yamabe
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience.

Authors:  Umberto Baccarani; Riccardo Pravisani; Gian Luigi Adani; Dario Lorenzin; Vittorio Cherchi; Pierluigi Toniutto; Andrea Risaliti
Journal:  Liver Transpl       Date:  2015-10-10       Impact factor: 5.799

3.  Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism.

Authors:  Xin-Hong He; Jian-Jian Gu; Wen-Tao Li; Wei-Jun Peng; Guo-Dong Li; Sheng-Ping Wang; Li-Chao Xu; Jun Ji
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

4.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

5.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

6.  Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.

Authors:  T Fukuda; S Hirota; K Sugimura
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

7.  Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience.

Authors:  Naftali Presser; Cristiano Quintini; Cynthia Tom; Weiping Wang; Qiang Liu; Teresa Diago-Uso; Masato Fujiki; Charles Winans; Dympna Kelly; Federico Aucejo; Koji Hashimoto; Bijan Eghtesad; Charles Miller
Journal:  Liver Transpl       Date:  2015-04       Impact factor: 5.799

8.  Management of splenic artery aneurysms and false aneurysms with endovascular treatment in 12 patients.

Authors:  R Guillon; J M Garcier; A Abergel; R Mofid; V Garcia; T Chahid; A Ravel; D Pezet; L Boyer
Journal:  Cardiovasc Intervent Radiol       Date:  2003 May-Jun       Impact factor: 2.740

9.  Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts.

Authors:  Sémia H Zidi; David Zanditenas; Moana Gelu-Siméon; Anne-Sophie Rangheard; Dominique C Valla; Valérie Vilgrain; Gilles M Pelletier
Journal:  Liver Int       Date:  2007-12       Impact factor: 5.828

Review 10.  Clinical application of partial splenic embolization.

Authors:  Yong-Song Guan; Ying Hu
Journal:  ScientificWorldJournal       Date:  2014-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.